Authors: Louis Michel, Charles Goerens, Antonya Parvanova, Frédérique Ries, Olle Schmidt on behalf of the ALDE Group, Maria Da Graça Carvalho, Nessa Childers, Marc Tarabella, Bart Staes, Marina Yannakoudadis
"Member States and the EU have invested heavily in research and innovation (R&D Programmes 5, 6 and 7) on the development of vaccines against tuberculosis.
Indeed, 5 years ahead of the deadline for the realisation of the MDGs, the incidence of tuberculosis in the world remains a cause for concern.
This requires strengthening international financing using existing methods.
What actions does the commission intent?"
See oral question here